share_log

Capital Allocation Trends At Cowealth Medical ChinaLtd (SHSE:603122) Aren't Ideal

Capital Allocation Trends At Cowealth Medical ChinaLtd (SHSE:603122) Aren't Ideal

Cowealth Medical ChinaLtd(SHSE: 603122)的資本配置趨勢並不理想
Simply Wall St ·  04/16 22:57

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding base of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. However, after briefly looking over the numbers, we don't think Cowealth Medical ChinaLtd (SHSE:603122) has the makings of a multi-bagger going forward, but let's have a look at why that may be.

尋找具有大幅增長潛力的企業並不容易,但如果我們看幾個關鍵的財務指標,這是可能的。首先,我們希望看到經過驗證的 返回 關於正在增加的資本使用率(ROCE),其次是擴大 基礎 所用資本的比例。基本上,這意味着公司擁有可以繼續進行再投資的盈利計劃,這是複合機器的特徵。但是,在簡短地研究了這些數字之後,我們認爲Cowealth Medical ChinaLTD(SHSE: 603122)在未來不具備多袋公司的實力,但讓我們來看看爲什麼會這樣。

Understanding Return On Capital Employed (ROCE)

了解資本使用回報率 (ROCE)

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on Cowealth Medical ChinaLtd is:

如果你以前沒有與ROCE合作過,它會衡量公司從其業務中使用的資本中產生的 “回報”(稅前利潤)。Cowealth Medical ChinaLtd的計算公式爲:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已動用資本回報率 = 息稅前收益 (EBIT) ¥(總資產-流動負債)

0.055 = CN¥65m ÷ (CN¥1.5b - CN¥286m) (Based on the trailing twelve months to December 2023).

0.055 = 6500萬元人民幣 ÷(15億元人民幣-2.86億元人民幣) (基於截至2023年12月的過去十二個月)

Thus, Cowealth Medical ChinaLtd has an ROCE of 5.5%. Ultimately, that's a low return and it under-performs the Healthcare industry average of 10%.

因此,合富醫療中國有限公司的投資回報率爲5.5%。歸根結底,這是一個低迴報,其表現低於醫療保健行業10%的平均水平。

roce
SHSE:603122 Return on Capital Employed April 17th 2024
SHSE: 603122 2024 年 4 月 17 日動用資本回報率

Historical performance is a great place to start when researching a stock so above you can see the gauge for Cowealth Medical ChinaLtd's ROCE against it's prior returns. If you're interested in investigating Cowealth Medical ChinaLtd's past further, check out this free graph covering Cowealth Medical ChinaLtd's past earnings, revenue and cash flow.

歷史表現是研究股票的絕佳起點,因此在上方您可以看到Cowealth Medical ChinaLtd的投資回報率與先前的回報率對比的指標。如果你有興趣進一步調查Cowealth Medical ChinaLTD的過去,請查看這張免費圖表,該圖表涵蓋了Cowealth Medical ChinaLtd過去的收益、收入和現金流。

How Are Returns Trending?

退貨趨勢如何?

On the surface, the trend of ROCE at Cowealth Medical ChinaLtd doesn't inspire confidence. Over the last five years, returns on capital have decreased to 5.5% from 20% five years ago. And considering revenue has dropped while employing more capital, we'd be cautious. This could mean that the business is losing its competitive advantage or market share, because while more money is being put into ventures, it's actually producing a lower return - "less bang for their buck" per se.

從表面上看,Cowealth Medical ChinaLtd的投資回報率趨勢並不能激發信心。在過去五年中,資本回報率從五年前的20%下降到5.5%。考慮到在僱用更多資本的同時收入有所下降,我們會謹慎行事。這可能意味着該企業正在失去其競爭優勢或市場份額,因爲儘管向風險投資投入了更多的資金,但它產生的回報實際上更低—— “成本效益更低” 本身。

On a related note, Cowealth Medical ChinaLtd has decreased its current liabilities to 20% of total assets. So we could link some of this to the decrease in ROCE. What's more, this can reduce some aspects of risk to the business because now the company's suppliers or short-term creditors are funding less of its operations. Some would claim this reduces the business' efficiency at generating ROCE since it is now funding more of the operations with its own money.

與此相關的是,合富醫療中國有限公司已將其流動負債減少至總資產的20%。因此,我們可以將其中一些與投資回報率的下降聯繫起來。更重要的是,這可以降低業務風險的某些方面,因爲現在公司的供應商或短期債權人爲其運營提供的資金減少了。有人會聲稱這降低了企業產生投資回報的效率,因爲該公司現在正在用自己的資金爲更多的業務提供資金。

Our Take On Cowealth Medical ChinaLtd's ROCE

我們對Cowealth Medical ChinaLtd投資回報率的看法

We're a bit apprehensive about Cowealth Medical ChinaLtd because despite more capital being deployed in the business, returns on that capital and sales have both fallen. It should come as no surprise then that the stock has fallen 43% over the last year, so it looks like investors are recognizing these changes. With underlying trends that aren't great in these areas, we'd consider looking elsewhere.

我們對Cowealth Medical ChinaLtd有點擔憂,因爲儘管向該業務投入了更多資金,但該資本的回報率和銷售額都下降了。因此,該股去年下跌了43%也就不足爲奇了,因此投資者似乎已經意識到了這些變化。由於這些領域的潛在趨勢並不理想,我們會考慮將目光投向其他地方。

Since virtually every company faces some risks, it's worth knowing what they are, and we've spotted 4 warning signs for Cowealth Medical ChinaLtd (of which 1 shouldn't be ignored!) that you should know about.

由於幾乎每家公司都面臨一些風險,因此值得了解它們是什麼,我們已經發現了Cowealth Medical ChinaLtd的4個警告信號(其中1個不容忽視!)你應該知道的。

For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.

對於那些喜歡投資穩健公司的人,可以查看這份資產負債表穩健和股本回報率高的公司的免費清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論